Babler Martin 4
4 · Prelude Therapeutics Inc · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Babler Martin
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-12+38,000→ 38,000 totalExercise: $1.04Exp: 2035-06-11→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date.